Benucci, Maurizio <br/><br/>
Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?  [electronic resource] 

 -  Current rheumatology reviews  2014 
 - 131-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1875-6360 
<br/><br/><label>Standard No.: </label>10.2174/1573397111666150113215950  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--blood<br/>Biomarkers--blood<br/>Cartilage Oligomeric Matrix Protein--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Treatment Outcome